Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 3/6/2024
Southern Medical Journal
April 2009
Date: 04 2009
Moving beyond LDL-C: incorporating lipoprotein particle numbers and geometric parameters to improve clinical outcomes
Research Reports in Clinical Cardiology
2010;1:1 – 10
Date: 01 2010
Clinical Utility of Low-Density Lipoprotein Measurement in Management of Cardiovascular Disease: A Case Study
Research Reports in Clinical Cardiology
2011: 2
Date: 01 2011
Effects of an Office-Based Carotid Ultrasound Screening Intervention. J Am Soc Echocardiography
J Am Soc Echocardiography
2011, 24:7, April 6
Date: 04 2011
Opportunities for Using Lipoprotein Subclass Profile by Nuclear Magnetic Resonance Spectroscopy
in Assessing Insulin Resistance and Diabetes Prediction
Metabolic Syndrome and Related Disorders
Volume: 2012
Date: 01 2012
Targeting insulin resistance: the ongoing paradigm shift in diabetes prevention
Am J Manag Care
2013;19(2):SP61-SP66
Date: 01 2013
www.taradall.com
Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c and Is Associated with Improved Glycemic Control in Clinical Practice
Cardiovasc Transl Res
Volume: 7:6
Date: 07 2014
Serum alpha-hydroxybutyrate (α-HB) predicts elevated 1-hour glucose levels and early-phase β-cell dysfunction during OGTT
BMJ Open Diabetes Res Care
24:2 (1)
Date: 09 2014
Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice
J Clin Lipidol
Volume: 9:2
Date: 03 2015
: http://dx.doi.org/10.1016/j.jacl.2014.11.005
Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population
Journal of Clinical Lipidology
Volume: 9:6
Date: 12 2015
